Mafalda Pereira

Company: Boehringer Ingelheim

Job title: Lab Head & Senior Scientist

Seminars:

Mechanistic Insights Into Survodutide, a Dual Glucagon/GLP-1 Receptor Agonist, for Obesity Treatment 12:30 pm

Exploring the potential of dual and triple receptor agonists targeting multiple pathways involved in energy regulation, such as GLP-1, GIP, and glucagon receptors, to achieve weight loss with improved tolerability profiles Evaluating their clinical and metabolic benefits, and their potential to address gastrointestinal side effects while maintaining potent weight loss efficacy Understanding receptor interactions and…Read more

day: Day One